APD371, a peripherally restricted, highly selective, full agonist of the Cannabinoid Receptor 2 (CB2), reduces colitis-induced visceral hypersensitivity in rats

被引：0
|
作者：
Brierley, S. [1 ]
Castro, J. [1 ]
Maddern, J. [1 ]
Garcia-Caraballo, S. [1 ]
Lindstrom, B. [2 ]
Adams, J. [2 ]
机构：
[1] Flinders Univ S Australia, Adelaide, SA, Australia
[2] Arena Pharmaceut Inc, San Diego, CA USA
来源：
NEUROGASTROENTEROLOGY AND MOTILITY | 2018年 / 30卷
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
042
引用
收藏
页数：2
相关论文
共 50 条
  • [21] Development of fluorinated and methoxylated benzothiazole derivatives as highly potent and selective cannabinoid CB2 receptor ligands
    Aly, Mayar W.
    Ludwig, Friedrich-Alexander
    Deuther-Conrad, Winnie
    Brust, Peter
    Abadi, Ashraf H.
    Moldovan, Rares-Petru
    Osman, Noha A.
    BIOORGANIC CHEMISTRY, 2021, 114
  • [22] Anti-inflammatory and antinociceptive effects of the selective cannabinoid CB2 receptor agonist ABK5
    Tang, Yaliang
    Wolk, Barbara
    Britch, Stevie C.
    Craft, Rebecca M.
    Kendall, Debra A.
    JOURNAL OF PHARMACOLOGICAL SCIENCES, 2021, 145 (04) : 319 - 326
  • [23] CANNABINOID RECEPTOR 2 (CB2) LOCALIZATION IN COLONIC TISSUE AND PRIMARY SENSORY DORSAL ROOT GANGLIA (DRG) NEURONS ISOLATED FROM RODENTS WITH COLITIS AND CHRONIC VISCERAL HYPERSENSITIVITY
    Castro, Joel
    Maddern, Jessica
    Garcia-Caraballo, Sonia
    Schober, Gudrun
    Lindstrom, Beartiz
    Schmiel, Shirdi
    Brierley, Stuart
    GASTROENTEROLOGY, 2021, 160 (06) : S503 - S504
  • [24] Influence of nicotinic receptor modulators on CB2 cannabinoid receptor agonist (JWH133)-induced antinociception in mice
    Jafari, Mohammad R.
    Golmohammadi, Somaye
    Ghiasvand, Fereshteh
    Zarrindast, Mohammad R.
    Djahanguiri, Bijan
    BEHAVIOURAL PHARMACOLOGY, 2007, 18 (07): : 691 - 697
  • [25] In vitro and in vivo characterization of an orally-active Cannabinoid receptor 2 (CB2)-selective agonist, M68400
    Masubuchi, Kazuhiro
    Kato, Yutaka
    Sogawa, Yoshitaka
    Okano, Akihiro
    Yumiya, Yasunobu
    Naba, Hiroyasu
    Muramatsu, Hiroyuki
    Nishiyama, Yuuichi
    Haruyama, Toshio
    Yamasaki, Fumiaki
    Furusako, Shoji
    JOURNAL OF PHARMACOLOGICAL SCIENCES, 2008, 106 : 247P - 247P
  • [26] A CB2 cannabinoid receptor agonist attenuates the viscero-visceral hyper-reflexia associated with a rat model of persistent visceral pain
    Jaggar, SI
    Rice, ASC
    JOURNAL OF PHYSIOLOGY-LONDON, 1998, 507P : 18P - 19P
  • [27] Cannabinoid Receptor 2 (CB2) Inverse Agonist SMM-189 Induces Expression of Endogenous CB2 and Protein Kinase A That Differentially Modulates the Immune Response and Suppresses Experimental Colitis
    Kiran, Sonia
    Rakib, Ahmed
    Moore, Bob M.
    Singh, Udai P.
    PHARMACEUTICS, 2022, 14 (05)
  • [28] The cannabinoid CB2 receptor agonist GW405833 does not ameliorate brain damage induced by hypoxia-ischemia in rats
    Rivers-Auty, J. R.
    Smith, P. F.
    Ashton, J. C.
    NEUROSCIENCE LETTERS, 2014, 569 : 104 - 109
  • [29] Cannabinoid 2 (CB2) receptor agonism reduces lithium chloride-induced vomiting in Suncus murinus and nausea-induced conditioned gaping in rats
    Rock, Erin M.
    Boulet, Nathalie
    Limebeer, Cheryl L.
    Mechoulam, Raphael
    Parker, Linda A.
    EUROPEAN JOURNAL OF PHARMACOLOGY, 2016, 786 : 94 - 99
  • [30] The anti-hyperalgesic actions of the cannabinoid anandamide and the putative CB2 receptor agonist palmitoylethanolamide in visceral and somatic inflammatory pain
    Jaggar, SI
    Hasnie, FS
    Sellaturay, S
    Rice, ASC
    PAIN, 1998, 76 (1-2) : 189 - 199
12345